Bristol-Myers Squibb Co
(WBO:BMYS)
€
38.95
0.575 (1.5%)
Market Cap: 77.78 Bil
Enterprise Value: 122.23 Bil
PE Ratio: 0
PB Ratio: 5.06
GF Score: 75/100 - Q1 2024 Bristol-Myers Squibb Co Earnings Call TranscriptApr 25, 2024€41.87 (-8.09%)Earnings
- Bristol-Myers Squibb Co at Barclays Global Healthcare Conference TranscriptMar 14, 2024
- Bristol-Myers Squibb Co at Leerink Partners Global Biopharma Conference TranscriptMar 13, 2024
- Bristol-Myers Squibb Co at TD Cowen Health Care Conference TranscriptMar 04, 2024
- Q4 2023 Bristol-Myers Squibb Co Earnings Call TranscriptFeb 02, 2024€45.45 (+2.02%)Earnings
- Bristol-Myers Squibb Co at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Bristol-Myers Squibb Co at Goldman Sachs Healthcare C-Suite Unscripted Conference TranscriptJan 04, 2024
- Bristol-Myers Squibb Co to Acquire Karuna Therapeutics Inc-M&A Call TranscriptDec 22, 2023
- Bristol-Myers Squibb Co at Jefferies London Healthcare Conference TranscriptNov 16, 2023
- Bristol-Myers Squibb Co at UBS BioPharma Conference TranscriptNov 08, 2023
- Q3 2023 Bristol-Myers Squibb Co Earnings Call TranscriptOct 26, 2023Earnings
- Bristol-Myers Squibb Co R&D Day TranscriptSep 14, 2023
- Bristol-Myers Squibb Co at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 Bristol-Myers Squibb Co Earnings Call TranscriptJul 27, 2023€55.9 (-2.44%)Earnings
- Bristol-Myers Squibb Co at Goldman Sachs Healthcare Conference TranscriptJun 13, 2023
- Bristol-Myers Squibb Co at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Bristol-Myers Squibb Co Virtual Investor Event: ASCO 2023 TranscriptJun 06, 2023
- Bristol-Myers Squibb Co at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 Bristol-Myers Squibb Co Earnings Call TranscriptApr 27, 2023€61 (-0.97%)Earnings
- Bristol-Myers Squibb Co at Cowen Health Care Conference TranscriptMar 07, 2023
- Bristol-Myers Squibb Co at Guggenheim Healthcare Talks Oncology Day TranscriptFeb 09, 2023
- Q4 2022 Bristol-Myers Squibb Co Earnings Call TranscriptFeb 02, 2023€64.53 (-1.90%)Earnings
- Bristol-Myers Squibb Co at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Bristol-Myers Squibb Co at Wolfe Research Healthcare Conference TranscriptNov 16, 2022
- Q3 2022 Bristol-Myers Squibb Co Earnings Call TranscriptOct 26, 2022€73.05Earnings
- Bristol-Myers Squibb Co at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Bristol-Myers Squibb Co at Citi BioPharma Conference TranscriptSep 08, 2022
- Bristol-Myers Squibb Co Investor Event TranscriptAug 28, 2022
- Q2 2022 Bristol-Myers Squibb Co Earnings Call TranscriptJul 27, 2022€72.95 (+0.37%)Earnings
- Bristol-Myers Squibb Co at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Bristol-Myers Squibb Co at Sanford C Bernstein Strategic Decisions Conference TranscriptJun 02, 2022
- Bristol-Myers Squibb Co at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Bristol-Myers Squibb Co Earnings Call TranscriptApr 29, 2022€71.25 (-2.13%)Earnings
- Bristol-Myers Squibb Co at Barclays Global Healthcare Conference - Fireside Chat TranscriptMar 16, 2022
- Bristol-Myers Squibb Co at Guggenheim Healthcare Talks: Targeted Protein Degradation Day (Virtual) - Fireside Chat TranscriptMar 16, 2022
- Q4 2021 Bristol-Myers Squibb Co Earnings Call TranscriptFeb 04, 2022€56.6 (+1.38%)Earnings
- Bristol-Myers Squibb Co at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Bristol-Myers Squibb Co at Wolfe Research Healthcare Conference (Virtual) TranscriptNov 17, 2021
- Bristol-Myers Squibb Co Investor Event TranscriptNov 16, 2021
- Q3 2021 Bristol-Myers Squibb Co Earnings Call TranscriptOct 27, 2021€49.34 (-1.08%)Earnings
- Bristol-Myers Squibb Co at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Q2 2021 Bristol-Myers Squibb Co Earnings Call TranscriptJul 28, 2021€58.16 (+2.23%)Earnings
- Bristol-Myers Squibb Co at William Blair Biotech Focus Conference (Virtual) TranscriptJul 14, 2021
- Bristol-Myers Squibb Co at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Bristol-Myers Squibb Co Investor Event to Discuss Data Presented at ASCO TranscriptJun 08, 2021
- Bristol-Myers Squibb Co at Sanford C Bernstein Strategic Decisions Conference (Virtual) TranscriptJun 02, 2021
- Bristol-Myers Squibb Co at UBS Global Healthcare Virtual Conference TranscriptMay 25, 2021
- Bristol-Myers Squibb Co at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Bristol-Myers Squibb Co at Truist Securities Life Sciences Summit (May Series) TranscriptMay 05, 2021
- Bristol-Myers Squibb Co Annual Shareholders Meeting TranscriptMay 04, 2021
- Q1 2021 Bristol-Myers Squibb Co Earnings Call TranscriptApr 29, 2021€52.2 (-4.43%)Earnings
- Bristol-Myers Squibb Co Virtual Investor Event to Discuss AAD VMX Highlights TranscriptApr 23, 2021
- Bristol-Myers Squibb Co at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Bristol-Myers Squibb Co at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- Bristol-Myers Squibb Co at Raymond James Institutional Investors Conference (Virtual) TranscriptMar 02, 2021
- Bristol-Myers Squibb Co at Guggenheim Partners Healthcare Talks Oncology Days TranscriptFeb 12, 2021
- Q4 2020 Bristol-Myers Squibb Co Earnings Call TranscriptFeb 04, 2021€51.97 (+0.29%)Earnings
- Bristol-Myers Squibb Co at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Bristol-Myers Squibb Co at Wolfe Research Healthcare Conference (Virtual) TranscriptNov 18, 2020
- Q3 2020 Bristol-Myers Squibb Co Earnings Call TranscriptNov 05, 2020€54.31 (-3.23%)Earnings
- Bristol-Myers Squibb Co Investor Event to Discuss Results from Phase 3 True North Trial Evaluating Zeposia (ozanimod) in Ulcerative Colitis at UEG Week 2020 TranscriptOct 12, 2020
- Bristol-Myers Squibb Company, MyoKardia, Inc. - M&A Call TranscriptOct 05, 2020
- Bristol-Myers Squibb Co Investor Event at European Society of Medical Oncology TranscriptSep 21, 2020
- Bristol-Myers Squibb Co at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Bristol-Myers Squibb Co at Citi BioPharma Conference (Virtual) TranscriptSep 08, 2020
- Q2 2020 Bristol-Myers Squibb Co Earnings Call TranscriptAug 06, 2020€51.72 (+2.95%)Earnings
- Bristol-Myers Squibb Co Three-Part Investor Series: Immunology and Cardiovascular TranscriptJun 26, 2020
- Bristol-Myers Squibb Co Three-Part Investor Series: Hematology TranscriptJun 25, 2020
- Bristol-Myers Squibb Co Three-Part Investor Series: Early Pipeline and Immuno-Oncology TranscriptJun 22, 2020
- Bristol-Myers Squibb Co at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 11, 2020
- Bristol-Myers Squibb Co at UBS Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- bluebird bio Inc and Bristol-Myers Squibb Co to Provide Regulatory Update on Idecabtagene Vicleucel - Conference Call TranscriptMay 13, 2020
- Bristol-Myers Squibb Co and bluebird bio Inc to Provide Regulatory Update on Idecabtagene Vicleucel - Conference Call TranscriptMay 13, 2020
- Q1 2020 Bristol-Myers Squibb Co Earnings Call TranscriptMay 07, 2020€57.06 (+0.48%)Earnings
- Bristol-Myers Squibb Co Annual Shareholders Meeting TranscriptMay 05, 2020
- Q4 2019 Bristol-Myers Squibb Co Earnings Call TranscriptFeb 06, 2020€60.56 (+1.49%)Earnings
- Roche Holding AG, Bristol-Myers Squibb Co and PhRMA at JPMorgan Healthcare Conference - Panel Session TranscriptJan 15, 2020
- Bristol-Myers Squibb Co at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Bristol-Myers Squibb Co at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top TranscriptJan 09, 2020
- Bristol-Myers Squibb Co to Hold Investor Webcast to Discuss ASH Highlights TranscriptDec 09, 2019
- Bristol-Myers Squibb Co at Wolfe Research Inaugural Healthcare Conference TranscriptNov 06, 2019
- Q3 2019 Bristol-Myers Squibb Co Earnings Call TranscriptOct 31, 2019€51.75 (+1.41%)Earnings
- Bristol-Myers Squibb Co to Discuss ESMO Highlights Call TranscriptSep 28, 2019
- Bristol-Myers Squibb Co at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Bristol-Myers Squibb Co Earnings Call TranscriptJul 25, 2019€40.74 (+5.98%)Earnings
- Bristol-Myers Squibb Co at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- Bristol-Myers Squibb Co Annual Shareholders Meeting TranscriptMay 29, 2019
- Bristol-Myers Squibb Co at UBS Global Healthcare Conference TranscriptMay 21, 2019
- Q1 2019 Bristol-Myers Squibb Co Earnings Call TranscriptApr 25, 2019Earnings
- Bristol-Myers Squibb Co at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Bristol-Myers Squibb Co at Cowen Health Care Conference TranscriptMar 12, 2019
- Bristol-Myers Squibb Co at Guggenheim Partners Oncology Day TranscriptFeb 14, 2019
- Q4 2018 Bristol-Myers Squibb Co Earnings Call TranscriptJan 24, 2019Earnings
Bristol-Myers Squibb Co at Barclays Global Healthcare Conference - Fireside Chat Transcript
Mar 16, 2022 / 05:35PM GMT
Release Date Price:
€63.13
(-0.75%)
Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst
Good afternoon, and welcome to the Barclays Global Healthcare Conference. My name is Carter Gould, senior biopharma analyst here at Barclays. Welcome. And next up is Bristol-Myers Squibb. We're really happy to have Bristol here, again, one of these companies that we've been looking forward to meet in person over the past 2 years. And joining from the company is the CMO and Head of Global Drug Development, Samit Hirawat. Samit, thank you very much for joining us today.
Samit Hirawat
Bristol-Myers Squibb Company - Executive VP & Chief Medical Officer of Global Drug Development
Thank you, Carter. Pleasure.
Questions & Answers
Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst
And in contrast to many of your peers, you have a very active 2022 from a catalyst perspective. A lot of clinical data, a number of launches coming up, so no shortage of stuff to talk about today. And in fact, you had a very busy week
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)